This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Sep 9;179(6):549-53.

doi: 10.1503/cmaj.080484.

The "number needed to treat" turns 20--and continues to be used and misused

Finlay A McAlister¹

Affiliations

PMID: 18779528
PMCID: PMC2527399
DOI: 10.1503/cmaj.080484

The "number needed to treat" turns 20--and continues to be used and misused

Finlay A McAlister. CMAJ. 2008.

. 2008 Sep 9;179(6):549-53.

doi: 10.1503/cmaj.080484.

Author

Finlay A McAlister¹

Affiliation

¹ Dr. McAlister is from The Division of General Internal Medicine, University of Alberta, Edmonton, AB. Finlay.McAlister@ualberta.ca

PMID: 18779528
PMCID: PMC2527399
DOI: 10.1503/cmaj.080484

No abstract available

PubMed Disclaimer

Comment in

Number needed to treat and baseline risks.
McCormack JP. McCormack JP. CMAJ. 2008 Nov 18;179(11):1174. doi: 10.1503/cmaj.1080110. CMAJ. 2008. PMID: 19015570 Free PMC article. No abstract available.

Similar articles

Using the number needed to treat in clinical practice.
Weeks DL, Noteboom JT. Weeks DL, et al. Arch Phys Med Rehabil. 2004 Oct;85(10):1729-31. doi: 10.1016/j.apmr.2004.03.025. Arch Phys Med Rehabil. 2004. PMID: 15468039
Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
Zaslavsky BG. Zaslavsky BG. J Biopharm Stat. 2007;17(3):481-91. doi: 10.1080/10543400701199601. J Biopharm Stat. 2007. PMID: 17479395
[Number needed to treat (NNT)-- misleading, misunderstood, misused?].
Wisløff T, Halvorsen PA, Kristiansen IS. Wisløff T, et al. Tidsskr Nor Laegeforen. 2004 Aug 12;124(15):1926-9. Tidsskr Nor Laegeforen. 2004. PMID: 15306861 Norwegian.
[Methodology for superiority versus equivalence and non-inferior clinical studies. A practical review].
Rosas-Peralta M, Santos-Martínez LE, Magaña-Serrano JA, Valencia-Sánchez JS, Garrido-Garduño M, Pérez-Rodríguez G. Rosas-Peralta M, et al. Rev Med Inst Mex Seguro Soc. 2016 May-Jun;54(3):344-53. Rev Med Inst Mex Seguro Soc. 2016. PMID: 27100981 Review. Spanish.
A user's review of commercial sample size software for design of biomedical studies using survival data.
Iwane M, Palensky J, Plante K. Iwane M, et al. Control Clin Trials. 1997 Feb;18(1):65-83. doi: 10.1016/s0197-2456(96)00139-0. Control Clin Trials. 1997. PMID: 9055054 Review. No abstract available.

See all similar articles

Cited by

Does Hospital Admission/Observation for Chest Pain Improve Patient Outcomes after Emergency Department Evaluation for Suspected Acute Coronary Syndrome?
Sharp AL, Kawatkar AA, Baecker AS, Redberg RF, Lee MS, Ferencik M, Wu YL, Shen E, Zheng C, Park S, Goodacre S, Thokala P, Sun BC. Sharp AL, et al. J Gen Intern Med. 2022 Mar;37(4):745-752. doi: 10.1007/s11606-021-06841-2. Epub 2021 May 14. J Gen Intern Med. 2022. PMID: 33987795 Free PMC article.
The changing cost-effectiveness of primary HIV prevention: simple calculations of direct effects.
Garnett GP, Herbeck JT, Akullian A. Garnett GP, et al. J Int AIDS Soc. 2025 May;28(5):e26494. doi: 10.1002/jia2.26494. J Int AIDS Soc. 2025. PMID: 40375630 Free PMC article.
Quantifying the impact of community quarantine on SARS transmission in Ontario: estimation of secondary case count difference and number needed to quarantine.
Bondy SJ, Russell ML, Laflèche JM, Rea E. Bondy SJ, et al. BMC Public Health. 2009 Dec 24;9:488. doi: 10.1186/1471-2458-9-488. BMC Public Health. 2009. PMID: 20034405 Free PMC article.
IAPN: a simple framework for evaluating whether a population-based risk stratification tool will be cost-effective before implementation.
Wyatt S, Mohammed MA, Spilsbury P. Wyatt S, et al. Cost Eff Resour Alloc. 2024 Dec 4;22(1):90. doi: 10.1186/s12962-024-00594-5. Cost Eff Resour Alloc. 2024. PMID: 39633403 Free PMC article.
Number needed to treat and baseline risks.
McCormack JP. McCormack JP. CMAJ. 2008 Nov 18;179(11):1174. doi: 10.1503/cmaj.1080110. CMAJ. 2008. PMID: 19015570 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33. - PubMed
1. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91;9:30. - PubMed
1. Muir Gray JA. Evidence-based healthcare: how to make health policy and management decisions. Edinburgh: Churchill Livingstone, 1997.
1. Kumana CR, Cheung BMY, Lauder IJ. Gauging the impact of statins using number needed to treat. JAMA 1999;282:1899-901. - PubMed
1. Osiri M, Suarez-Almazor ME, Wells GA, et al. Number needed to treat (NNT): implication in rheumatology clinical practice. Ann Rheum Dis 2003;62:316-21. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information